Navigation Links
Cardium Reports On Third Quarter 2013 Financial Results And Recent Business Developments
Date:11/19/2013

September 30, 2013, the Company had $585,000 in cash and cash equivalents, compared to $2.3 million in cash and cash equivalents on December 31, 2012.  On September 30, 2013, 7,747,228 million shares of Cardium's common stock were outstanding. 

The sale of To Go Brands is intended to monetize that business by positioning it with a diversified, fast growing platform.  Cardium's preferred stock position in Cell-nique is convertible into common stock currently representing approximately 4% of the fully-diluted common stock, it accrues an 8% annual dividend, and it comes with certain rights and preferences described in Cell-nique's articles of incorporation. Cardium could also elect to sell or otherwise monetize its preferred stock position in Cell-nique in one or more transactions.

The To Go Brands transaction also included the transfer of certain operating expenses and liabilities to Healthy Brands Collective, which will further reduce the Company's operating expenses. In addition, during third quarter, Cardium implemented certain cost reductions that include relocating the Company to a smaller corporate office, as well as headcount and salary reductions.

The Company intends to consider additional corporate development transactions designed to place its product candidates or businesses into larger organizations or with partners having existing commercialization, sales and marketing resources, and a need for innovative products. Such transactions could involve the sale, partnering or other monetization of particular product opportunities or businesses. In parallel, as the Company's businesses are advanced and corresponding valuations established, it plans to pursue new product opportunities and acquisitions with strong value enhancement potential.

Cardium has also been approached by a strategic investor interested in potentially acquiring a stake in the company at a premium to market, although we have not entered into defin
'/>"/>

SOURCE Cardium Therapeutics
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine technology :

1. Unusual Trading Activity In Cardium Common Stock
2. Cardium Reports On Potential Use Of Excellagen To Repair Prenatally Diagnosed Birth Defects Using Mesenchymal Stem Cells
3. Cardium Announces New Excellagen FDA 510(k) Submission Based On Expanded Structural And Functional Properties
4. Cardium Reports On New Excellagen Distribution Agreement With AvKARE For Veterans Hospitals And Other Governmental Medical Facilities
5. Cardium Completes Preferred Stock Financing
6. Cardium Announces Reverse Stock Split
7. Cardium Announces Initial Voting Results And Temporary Adjournment of Annual Meeting To Be Reconvened On June 21, 2013
8. Cardium Presents First Quarter 2013 Financial Results And Reports On Recent Developments
9. Cardium Announces Generx Publication In Molecular Therapy
10. Cardium Announces Excellagen Presentation at the Symposium on Advanced Wound Care Spring 2013 Meeting
11. Cardium Presents Year-End 2012 Financial Results And Recent Developments
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... , Sept. 23, 2014  MEDIMETRIKS PHARMACEUTICALS today ... William Resnick have been elected to Medimetriks, ... Mr. Lary, who will serve on Medimetriks, ... investment experience to the Company.  Mr. Lary is ... LLC, a leading institutional investment firm.  Mr. Lary ...
(Date:9/23/2014)... 2014  Vesselon, Inc. today announced the appointment of ... September 15, 2014. Dr. Raths, appointment follows Vesselon,s engagement ... to market a private preferred Series A round to ... "Jurgen,s deep experience across multiple functional areas ... to Vesselon as we develop our device that can ...
(Date:9/23/2014)... 23, 2014  KemPharm, Inc., a clinical-stage specialty ... of proprietary new molecular entity (NME) prodrugs, announced ... (NOL) from Health Canada to begin clinical trials ... lead product candidate KP201 (benzhydrocodone hydrochloride and acetaminophen).  ... acute moderate to moderately severe pain. The Health ...
Breaking Medicine Technology:Medimetriks Pharmaceuticals, Inc. Welcomes Independent Directors Andrew Lary and William Resnick to its Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 2Vesselon Announces Jurgen Raths, MD to Serve on Board of Directors 3KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 2KemPharm Receives Health Canada Approval to Begin KP201 Clinical Trials in Canada 3
... 7 Genomic Health,Inc. (Nasdaq: GHDX ) ... the,company,s Oncotype DX(R) breast cancer test are scheduled ... Breast Cancer Symposium, taking place,December 13-16, 2007. Oncotype ... to predict the likelihood of recurrence and the ...
... PROCRIT(R) (Epoetin alfa),studies will be presented at the American Society of ... The data will provide important insights including:, ... limiting the use of erythropoiesis-stimulating agents (ESAs) ... -- the use of PROCRIT in extended dosing regimens; ...
Cached Medicine Technology:Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium 2Genomic Health Announces Eight Oncotype DX(R) Studies to Be Presented at 30th Annual San Antonio Breast Cancer Symposium 3PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 2PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 3PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 4PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 5PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 6PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 7PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 8PROCRIT(R) (Epoetin Alfa) Data to be Presented at American Society of Hematology Annual Meeting 9
(Date:9/23/2014)... The Sloane Clinic™, a leading ... Malaysia providing advanced aesthetic dermatology and cosmetic solutions ... impressive skin care repertoire. Specially formulated with super-powered ... the evil forces of aging, acne and photo ... new addition is revolutionizing the way we treat ...
(Date:9/23/2014)... September 23, 2014 The University ... research university located In the Piedmont Triad, announced ... as co-director of the Center for Translational Biomedical ... comes to UNCG after nearly a decade at ... Laboratory, Biological Sciences Division. , “Our goal ...
(Date:9/23/2014)... HealthDay Reporter MONDAY, ... marches demanding action on climate change, a new study ... the United States may soon exacerbate many existing health ... illnesses are expected to increase as the number of ... Patz, director of the Global Health Institute at the ...
(Date:9/23/2014)... Randy Dotinga HealthDay Reporter ... using cholesterol-lowering drugs while in the hospital for a hemorrhagic ... more than four times more likely to survive than people ... People taking the commonly used drugs known as statins ... or to a rehabilitation facility, the study reports. When ...
(Date:9/23/2014)... Hospital Medical Center have published the first study ... published in The Journal of Allergy and ... systemic disorder that has high levels of eosinophils ... series of allergy-associated-immune mechanisms and has a gene ... of a related disorder, eosinophilic esophagitis (EoE). ...
Breaking Medicine News(10 mins):Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 2Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 3Health News:The Sloane Clinic™ introduces a revolutionary BB powder to its impressive skin care repertoire 4Health News:Former Department of Energy Scientist Joins UNCG as Co-director of Biomedical Research Center 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 2Health News:Health Woes to Worsen Due to Climate Change, Study Warns 3Health News:Cholesterol-Lowering Drugs May Help After Certain Strokes 2Health News:Cholesterol-Lowering Drugs May Help After Certain Strokes 3Health News:Advancing the understanding of an understudied food allergy disorder 2Health News:Advancing the understanding of an understudied food allergy disorder 3
... well, sports commentators may describe them as being "hot" or ... the eye of the beholder, but a new study by ... that a streak of positive outcomes is likely to continue., ... the study analyzed five years of NBA free throws that ...
... HealthDay Reporter , WEDNESDAY, Oct. 5 (HealthDay News) -- Older ... a greater risk of developing dementia than folks who believe ... the journal Neurology . Someday, "having people rate ... to determine a person,s risk of dementia, especially for people ...
... By Steven Reinberg HealthDay Reporter , WEDNESDAY, Oct. ... forms of multiple sclerosis appears to reduce relapse rates and ... 3 trial. The experimental drug, teriflunomide, is one of ... and may, if approved, be a good choice for many ...
... Oct. 5 (HealthDay News) -- The percentage of nursing ... flu shot is lower than the national goal, and the ... study finds. Brown University researchers examined annual patient records ... 2006-07 to 2008-09. The overall flu vaccination rate for ...
... , WEDNESDAY, Oct. 5 (HealthDay News) -- Nearly one in ... center than 10 years ago due to closures of hospital ... had the greatest impact on black people, the poor, the ... San Francisco researchers. "Trauma centers aren,t just for ,certain, ...
... life experiences -- the ups and downs, and everything in ... emotional set point as adults, according to a new study ... suggests that, in addition to our genes, our life experiences ... "In this time of emphasis on genes for this ...
Cached Medicine News:Health News:Athletes' winning streaks may not be all in our -- or their -- heads 2Health News:Gauging General Health as 'Poor' May Point to Dementia Risk 2Health News:Experimental MS Drug Shows Promise 2Health News:Experimental MS Drug Shows Promise 3Health News:Nursing Homes Not Meeting Flu-Shot Goals, Study Says 2Health News:More Americans Face Longers Trips to ER 2Health News:Virginia Commonwealth University study: We are what we experience 2
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: